GLP-1 · Eli Lilly
Foundayo (orforglipron)
Once-daily oral GLP-1 receptor agonist FDA-approved on April 1, 2026 for long-term weight management in eligible adults, alongside a reduced-calorie diet and increased physical activity. FDA approval does not establish an Ondoc prescribing program or pharmacy availability.
FDA-approved for
- Long-term weight management in adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity
Cash reference: Check current pharmacy pricing
Why Ondoc for Foundayo
- Discuss medication options through the existing weight-management visit
- Insurance coverage depends on your individual plan
- No prescription or pharmacy availability is guaranteed
Savings pathways for Foundayo
Compare available insurance, self-pay, and coupon options for Foundayo.
Common questions about Foundayo
Can I use insurance for weight management with Ondoc?
Ondoc accepts Medicare and supported commercial insurance for clinical care; coverage for your weight-management visit is verified for your individual plan and service. General weight-management visits are $50 self-pay; the existing Qsymia evaluation is $100. Medication coverage depends on your plan.
Does Ondoc prescribe Wegovy, Zepbound or other GLP-1s?
Ondoc treats weight management, and GLP-1 medications such as Wegovy and Zepbound are among the options. Your Ondoc clinician decides what fits you.
Do I need a membership or subscription?
No. You can book a one-time visit. A membership is optional.
How do I start?
Pick insurance or self-pay, choose an available appointment time, and book.
Are compounded GLP-1s an option?
Ondoc prescribes FDA-approved GLP-1 medications and does not route these drugs to compounding pharmacies.